Nectar Lifescience consolidated net profit rises 63.19% in the June 2024 quarter

Net profit of Nectar Lifescience rose 63.19% to Rs 2.97 crore in the quarter ended June 2024 as against Rs 1.82 crore during the previous quarter ended June 2023. Sales declined 8.95% to Rs 358.85 crore in the quarter ended June 2024 as against Rs 394.12 crore during the previous quarter ended June 2023.

Particulars	Quarter Ended
	Jun. 2024	Jun. 2023	% Var.
Sales	358.85	394.12	-9
OPM %	11.09	9.02	-
PBDT	20.38	18.39	11
PBT	4.92	3.06	61
NP	2.97	1.82	63